Tag: Research and development

AIHardwareTechnology

Google and Anthropic Forge Landmark AI Compute Partnership Valued at Tens of Billions

In a massive expansion of their existing partnership, Google will provide Anthropic with access to up to a million Tensor Processing Units. The deal, reportedly involving tens of billions of dollars, is set to fuel the development of future Claude AI models and underscores the intense demand for advanced AI infrastructure.

Unprecedented Scale in AI Compute

Google and AI research company Anthropic have solidified a monumental agreement that will see Anthropic gain access to a computing resource of nearly one million of Google’s custom Tensor Processing Units (TPUs), according to reports from both companies. The deal, announced recently, is said to involve financial commitments in the tens of billions of dollars, marking one of the largest known AI infrastructure partnerships to date.

by Ortega Rafael
BusinessManufacturing

Fortescue Shifts Manufacturing to China, UK Layoffs Impact Net Zero Plans

Fortescue Metals Group is restructuring its Zero operations, shifting battery and power system manufacturing from Oxfordshire to China. The move impacts UK staff as the company prioritizes research and development over in-house production.

Australian mining giant Fortescue Metals Group has announced significant operational changes to its Zero emissions division, resulting in staff layoffs primarily affecting UK-based employees. The company, founded by billionaire Andrew Forrest, is shifting manufacturing of battery plants and power systems for its electric truck fleet from planned UK facilities to China, marking a strategic pivot in its ambitious carbon neutrality roadmap.

Strategic Shift in Manufacturing Operations

by Ortega Rafael
BusinessManufacturing

GSK’s $30 Billion U.S. Investment: AI-Powered Biopharma Expansion & Job Creation

Pharmaceutical giant GSK has committed $30 billion to U.S. operations over five years, featuring advanced AI manufacturing and new biologics facilities. This massive investment will create hundreds of skilled jobs while accelerating development of next-generation medicines for respiratory diseases and cancer.

In a landmark announcement that signals significant growth for the American pharmaceutical sector, global healthcare company GSK plc has revealed plans to invest $30 billion across the United States over the next five years. This substantial commitment to research and development and manufacturing infrastructure represents one of the largest pharmaceutical investments in recent U.S. history, with advanced artificial intelligence technologies playing a central role in modernizing production facilities and accelerating drug development.

Comprehensive U.S. Investment Strategy

by Ortega Rafael